Nalaganje...
A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier
The blood-brain barrier (BBB) protects the brain from toxic substances within the peripheral circulation. It maintains brain homeostasis and is a hurdle for drug delivery to the CNS to treat neurodegenerative diseases, including Alzheimer’s disease and brain tumors. The drug efflux transporter P-gly...
Shranjeno v:
| izdano v: | J Clin Invest |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Clinical Investigation
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4855938/ https://ncbi.nlm.nih.gov/pubmed/27043281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI76207 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|